Solution NMR structure and ligand identification of human Gas7 SH3 domain reveal a typical SH3 fold but a non-canonical ligand-binding mode.

Biochem Biophys Res Commun

State Key Laboratory of Magnetic Resonance and Atomic Molecular Physics, Key Laboratory of Magnetic Resonance in Biological Systems, National Center for Magnetic Resonance in Wuhan, Wuhan National Laboratory for Optoelectronics, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences, Wuhan, 430071, China; University of Chinese Academy of Sciences, Beijing, 100049, China. Electronic address:

Published: September 2019

AI Article Synopsis

  • Growth arrest specific 7 (Gas7) protein regulates the cytoskeleton and is important for neural cell development, being connected to diseases like Alzheimer’s and schizophrenia, as well as various cancers.
  • The study reveals the solution NMR structure of the hGas7 SH3 domain, which exhibits a typical SH3 fold but has a unique binding profile, suggesting it interacts with ligands differently than similar domains.
  • NMR titration results indicate that hGas7-SH3 has low affinity for the proline-rich ligand P41, with binding primarily occurring in the RT-loop region, highlighting its distinctive ligand-binding characteristics despite a similar structural appearance.

Article Abstract

Growth arrest specific 7 (Gas7) protein is a cytoskeleton regulator playing a crucial role in neural cell development and function, and has been implicated in Alzheimer disease, schizophrenia and cancers. In human, three Gas7 isoforms can be expressed from a single Gas7 gene, while only the longest isoform, hGas7c, possesses an SH3 domain at the N-terminus. To date, the structure and function of hGas7 SH3 domain are still unclear. Here, we reported the solution NMR structure of hGas7 SH3 domain (hGas7-SH3), which displays a typical SH3 β-barrel fold comprising five β-strands and one 3-helix. Structural and sequence comparison showed that hGas7-SH3 shares high similarity with Abl SH3 domain, which binds to a high-affinity proline-rich peptide P41 in a canonical SH3-ligand binding mode through two hydrophobic pockets and a specificity site in the RT-loop. However, unlike Abl-SH3, only six residues in the RT-loop and two residues adjacent to but not in the two hydrophobic pockets of hGas7-SH3 showed significant chemical shift perturbations in NMR titrations, suggesting a low affinity and a non-canonical binding mode of hGas7-SH3 for P41. Furthermore, four peptides selected from phage-displayed libraries also bound weakly to hGas7-SH3, and the binding region of hGas7-SH3 was mainly located in the RT-loop as well. The ligand identifications through structural similarity searching and peptide library screening in this study imply that although hGas7-SH3 adopts a typical SH3 fold, it probably possesses distinctive ligand-binding specificity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2019.07.004DOI Listing

Publication Analysis

Top Keywords

sh3 domain
20
typical sh3
12
solution nmr
8
nmr structure
8
sh3
8
sh3 fold
8
hgas7 sh3
8
binding mode
8
hydrophobic pockets
8
hgas7-sh3
7

Similar Publications

Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication and limited behavior. Despite the association of numerous synaptic gene mutations with ASD, the presence of behavioral abnormalities in mice expressing autism-associated R617W mutation in synaptic adhesion protein neuroligin-3 (NL3) has not been established. This work focuses on establishing a mouse model of ASD caused by NL3 R617W missense mutation (NL3R617W) and characterizing and profiling the molecular as well as behavioral features of the animal model.

View Article and Find Full Text PDF

Missense mutations in the TP53 (p53) gene have been linked to malignant progression. However, our in-silico analyses reveal that hepatocellular carcinoma (HCC) patients with mutant p53 (mutp53) have better overall survival compared to those with p53-null (p53) HCC, unlike other cancer types. Given the historical use of sorafenib (SOR) monotherapy for advanced HCC, we hypothesize that mutp53 increases sensitivity to SOR, a multikinase inhibitor that induces endoplasmic reticulum (ER) stress.

View Article and Find Full Text PDF

Insights into the diversity and conservation of the chB6 alloantigen.

Front Immunol

March 2025

Department of Biological Sciences, DePaul University, Chicago, IL, United States.

The bursa of Fabricius has been a durable model of B lymphocyte development. Yet there are unique aspects of B- lymphocyte development in the bursa that remain to be elucidated, and these may reveal important functional differences in the avian system and distinct evolutionary mechanisms from the canonical murine and human models of B- lymphocyte development. Our laboratory has been interested in the function of the chB6 alloantigen.

View Article and Find Full Text PDF

Engineered T cell therapies have emerged as a promising approach for cancer treatment, yet their application to solid tumors remains challenging due to the limited specificity and persistence of current antigen recognition strategies. Here, we introduced sherpabodies, engineered from a human SH3 domain scaffold, as a class of antibody-mimetic proteins capable of precise tumor-associated antigen recognition. A phage display library identified sherpabodies against a panel of popular tumor-associated antigens (TAA), which were subsequently incorporated into second-generation chimeric antigen receptor constructs that were termed sherpabody-guided CARs (SbCARs).

View Article and Find Full Text PDF

PPP1R13L drives cervical cancer progression by suppressing p63-mediated PTEN transcription.

Cell Mol Life Sci

February 2025

Department of Gynecological Oncology, Zhongnan Hospital, Wuhan University, Wuhan, People's Republic of China.

PPP1R13L is a conserved inhibitor of p53, selectively regulating a subset of p53 target genes. Previous studies have reported that PPP1R13L promotes cervical cancer progression, yet its precise mechanism remains unclear and warrants further investigation. In this study, we utilized public databases to reveal the correlation between PPP1R13L and tumor progression pathways.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!